1. ANALYSIS OF CLINICAL DETERMINANTS DRIVING SAFETY AND EFFICACY OF CAMIDANLUMAB TESIRINE (ADCT‐301, CAMI) IN RELAPSED/REFRACTORY (R/R) CLASSICAL HODGKIN LYMPHOMA (CHL). (12th June 2019) Authors: Collins, G.; Horwitz, S.; Hamadani, M.; Samaniego, F.; Spira, A.; Caimi, P.; Davies, A.; Menne, T.; Fields, P.; Cruz, H.; He, S.; Boni, J.; Feingold, J.; Wuerthner, J.; Radford, J. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 95 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Astrophysical neutrinos and cosmic rays observed by IceCube. Issue 10 (15th November 2018) Authors: Aartsen, M.G.; Ackermann, M.; Adams, J.; Aguilar, J.A.; Ahlers, M.; Ahrens, M.; Altmann, D.; Andeen, K.; Anderson, T.; Ansseau, I.; Anton, G.; Archinger, M.; Argüelles, C.; Auffenberg, J.; Axani, S.; Bai, X.; Barwick, S.W.; Baum, V.; Bay, R.; Beatty, J.J. Journal: Advances in space research Issue: Volume 62:Issue 10(2018) Page Start: 2902 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. EARLY PET RESPONSE PREDICTS OUTCOME IN LARGE B‐CELL LYMPHOMA PATIENTS TREATED WITH CD19 CAR‐T. (17th June 2021) Authors: Cuadrado, M.; Menne, T.; Petrides, G.; Osborne, W.; Potter, V.; Benjamin, R.; Patten, P.; Yallop, D.; Sanderson, R.; Mulholland, N.; Kuhnl, A. Journal: Hematological oncology Issue: Volume 39(2021)Supplement 2 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Efficient propagation of systematic uncertainties from calibration to analysis with the SnowStorm method in IceCube. Issue 10 (21st October 2019) Authors: Aartsen, M.G.; Ackermann, M.; Adams, J.; Aguilar, J.A.; Ahlers, M.; Alispach, C.; Atoum, B. Al; Andeen, K.; Anderson, T.; Ansseau, I.; Anton, G.; Argüelles, C.; Auffenberg, J.; Axani, S.; Backes, P.; Bagherpour, H.; Bai, X.; V., A. Balagopal; Barbano, A.; Barwick, S.W. Journal: Journal of cosmology and astroparticle physics Issue: Volume 2019:Issue 10(2019) Page Start: 048 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. In-situ calibration of the single-photoelectron charge response of the IceCube photomultiplier tubes. (1st June 2020) Authors: Aartsen, M.G.; Ackermann, M.; Adams, J.; Aguilar, J.A.; Ahlers, M.; Ahrens, M.; Alispach, C.; Andeen, K.; Anderson, T.; Ansseau, I.; Anton, G.; Argüelles, C.; Auffenberg, J.; Axani, S.; Backes, P.; Bagherpour, H.; Bai, X.; V., A. Balagopal; Barbano, A.; Barwick, S.W. Journal: Journal of instrumentation Issue: Volume 15:Number 6(2020) Page Start: P06032 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. MODIFICATION OF ESCALATED BEACOPP WITH DACARBAZINE / PROCARBAZINE SUBSTITUTION REDUCES RED CELL TRANSFUSION REQUIREMENTS AND MAY SHORTEN TIME TO MENSTRUAL PERIOD RECOVERY. (12th June 2019) Authors: Follows, G.; Santarsieri, A.; Sturgess, K.; Menne, T.; Osborne, W.; Creasey, T.; Ardeshna, K.M.; Behan, S.; Booth, S.; Collins, G.; Cwynarski, K.; Iyengar, S.; Jones, S.; Martinez‐Calle, N.; McKay, P.; Nagumantry, S.K.; O'Mahony, D.; Rudge, J.F.; Shah, N.; Stafford, G. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 490 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. NCRI PETREA TRIAL: A PHASE 3 EVALUATION OF PET‐GUIDED, RESPONSE‐ADAPTED THERAPY IN PATIENTS WITH PREVIOUSLY UNTREATED, ADVANCED‐STAGE, HIGH‐TUMOUR‐BURDEN FOLLICULAR LYMPHOMA. (12th June 2019) Authors: Pettitt, A.R.; Barrington, S.; Kalakonda, N.; Khan, U.T.; Jackson, R.; Carruthers, S.; Oates, M.; Lin, K.; Ardeshna, K.; Eyre, T.; Fox, C.P.; Kennedy, B.; Linton, K.; Malladi, R.; Menne, T.; Okosun, J.; Paneesha, S.; Rule, S.; Johnston, A.; Trotman, J. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 67 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. RESULTS OF a PHASE II STUDY OF BRENTUXIMAB VEDOTIN IN THE FIRST LINE TREATMENT OF HODGKIN LYMPHOMA PATIENTS CONSIDERED UNSUITABLE FOR STANDARD CHEMOTHERAPY (BREVITY). (June 2017) Authors: Gibb, A.; Pirrie, S.; Linton, K.; Paterson, K.; Davies, A.; Collins, G.; Menne, T.; McKay, P.; Fields, P.; Miall, F.; Nagy, E.; Wheatley, K.; Warbey, V.; Barrington, S.; Radford, J. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 80 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. S261: SAFETY AND PRELIMINARY EFFICACY FINDINGS OF AUTO4, A TRBC1-TARGETTING CAR, IN RELAPSED/REFRACTORY TRBC1 POSITIVE SELECTED T CELL NON-HODGKIN LYMPHOMA. (23rd June 2022) Authors: Cwynarski, K.; Tholouli, E.; Iacoboni, G.; Menne, T.; Irvine, D.; Wood, L.; Balasubramaniam, N.; Shang, J.; Zhang, M; Duffy, K.; Huber, B.; Vinson, M.; Brugger, W.; Pule, M. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 162 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗